by Steven Rudolph | Nov 13, 2022 | Uncategorized
We have known for many years that physical activity is able to decrease the risk of heart disease and stroke. Now we have new evidence that even small amounts of physical activity may have benefit in older individuals. People in their 80s were studied in this case....
by Steven Rudolph | Nov 2, 2022 | Uncategorized
In 1996, Alteplase, a clot dissolving drug also known as tPA became the first available treatment for the most common type of stroke. It revolutionized the treatment of stroke around the world....
by Steven Rudolph | May 10, 2019 | Uncategorized
A new study has demonstrated that some strokes may be treated later than was previously thought. The EXTEND study, performed in Australia, treated patients with the clot dissolving medication Alteplase (tPA) between 4.5 and 9 hours after the start of the stroke,...
by Steven Rudolph | Dec 10, 2018 | News, Uncategorized
The treatment of stroke patients has been characterized by the need for speed. The only medical therapy available, a clot dissolving drug called tPA, was originally available for use only if it could be given less than 3 hours after the start of symptoms. This led to...
by Steven Rudolph | Dec 14, 2015 | Uncategorized
The modern era of stroke treatment began 20 years ago today, with the publication of the NINDS tPA trial in The New England Journal of Medicine. Back in those days, stroke was not considered treatable, and there was no urgency attached to the care of stroke patients....
by Steven Rudolph | Jun 29, 2014 | Uncategorized
Atrial fibrillation is a type of irregular heartbeat that is quite common in the elderly. This condition results in the tendency for blood clots to originate in the heart and move into the brain, plugging blood vessels and causing a stroke. The strokes associated with...
Recent Comments